NCT01731912View on ClinicalTrials.gov

Degarelix Acetate Before and During Radiation Therapy in Treating Patients With Prostate Cancer

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Prostate AdenocarcinomaStage IIA Prostate CancerStage IIB Prostate CancerStage III Prostate CancerStage IV Prostate Cancer
Interventions
DRUG

Degarelix

Given SC

RADIATION

External Beam Radiation Therapy

Undergo standard EBRT

OTHER

Laboratory Biomarker Analysis

Correlative studies

Trial Locations (1)

98109

Fred Hutch/University of Washington Cancer Consortium, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Washington

OTHER

NCT01731912 - Degarelix Acetate Before and During Radiation Therapy in Treating Patients With Prostate Cancer | Biotech Hunter | Biotech Hunter